Given the facts that sunitinib has multiple pharmacological targets and that sunitinib treatment affects insulin clearance and insulin sensitivity, we therefore hypothesized that sunitinib-induced hypertension is associated with insulin resistance, insulin signaling and Pellino-1/AKT/eNOS pathways. The gene discussed is AKT1; the disease is Hypertension.